BAL PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.8 INR | +1.61% |
|
+1.18% | +19.25% |
| 05-28 | Bal Pharma Limited Recommends Dividend | CI |
| 05-28 | Bal Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 22.5M | - | - | - | - | - | |
| 796B | ||||||
| 628B | ||||||
| 358B | - | - | - | - | ||
| 331B | ||||||
| 301B |
